Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
about
An automated neural-fuzzy approach to malignant tumor localization in 2D ultrasonic images of the prostate.T1-weighted MR image contrast around a cryoablation iceball: a phantom study and initial comparison with in vivo findings.Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimensEndorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.A hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapyStereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsStatistical 3D Distribution Analysis of Prostate Cancers in Korean Using Digital Processing TechniquesProstate cancers in the transition zone: Part 2; clinical aspects.Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer.Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.Innovative strategies for image-guided proton treatment of prostate cancer.The diagnostic ability of an additional midline peripheral zone biopsy in transrectal ultrasonography-guided 12-core prostate biopsy to detect midline prostate cancerPEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluationHigh-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patientsImaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewDifferences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cellsThe relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.PET and PET/CT in radiation treatment planning for prostate cancer.Additional Midline Biopsies of the Peripheral Zone Associated with the First Endorectal Standard Sextant Pattern Improves the Accuracy of Prostate Cancer Detection in Japanese Patients.How does performance of ultrasound tissue typing affect design of prostate IMRT dose-painting protocols?A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy.Significant impact of transperineal template biopsy of the prostate at a single tertiary institution.Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation.Pros and cons of focal therapy for localised prostate cancer.Prostate biopsy in Central Europe: results of a survey of indication, patient preparation and biopsy technique.Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States.Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.Current standards and future directions for prostate cancer radiation therapy.Effects of sextant transrectal prostate biopsy plus additional far lateral cores in improving cancer detection rates in men with large prostate glands.Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.TRUS-guided transperineal prostate 12+X core biopsy with template for the diagnosis of prostate cancer.Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.Location of a positive biopsy as a predictor of surgical margin status and extraprostatic disease in radical prostatectomy.Endo-rectal balloon cavity dosimetry in a phantom: performance under IMRT and helical tomotherapy beams.High-intensity focused ultrasound therapy for clinically localized prostate cancer.
P2860
Q30467127-DB1F8246-01B6-46C4-A66F-A183C718A62EQ30867579-D80CC33D-6E92-4361-A46E-5E06CA2C4AD6Q33747053-9D8988F5-BCE5-43CE-A422-B64906B0A299Q34153708-8BDF332F-101C-43D9-861B-591686ACAC4FQ34498643-02DA264C-C160-42E2-8959-4F8AAEA32E34Q34592435-33E91883-D13D-4275-95F2-112CE9259453Q34660610-EF4E2807-79E0-4E8C-AEC1-821ECE977703Q34976166-1FF47603-E99F-416E-B250-642665AB163FQ35989437-02B1CD19-26FC-4E4A-81C1-97978534086EQ36127793-C6C41FBB-9206-488E-968C-ECA9ACF3123AQ36234065-849D16FA-2B3D-45FC-B7A1-A1436F7B427AQ36337195-DC489A2E-BB71-474F-AA2A-A2AE9CBF4433Q36427226-8FEAC401-9DF8-4B06-AACB-88ACEBBB572DQ36430461-766E312B-D060-4A2C-B42C-9858925C8CC6Q36550586-F0E0C129-46C8-4FCD-B976-99E1E973EEE8Q36726326-43189699-CD34-463B-88D1-119C9258B311Q36979944-5437DD02-09B0-4EAC-BB5D-AEF493CCDB4CQ37085297-99522CCD-CD5C-499B-ABD8-9FEE41F56CE0Q37431041-84124FF7-B153-4AE8-84EB-77A90BECAD8FQ37878465-70B14C07-4043-40F7-9BA9-01A1D5C6BE7CQ37909361-08F6854C-D4A8-44AA-9DCF-CE485066AAF5Q38343607-5A5E57C9-0D0D-44A7-93D8-031610D5046BQ38464445-F0057E3E-080F-4872-A6B1-C8712FCFF777Q38628595-83C3DA67-86A4-44F7-ADB2-62F99A6350C6Q38675981-ED95C2E4-0B26-4002-B372-E0C57F2924F9Q38779301-B56DF083-BA81-4B56-A973-004A85962537Q38807805-5F814542-1FD4-427E-BDF8-BFDAE37F0A61Q39213076-BCE33DD0-B2C5-41DA-A87D-151BB3C4F3D9Q39245025-DB009E04-5B65-4718-AD56-A05FA408D632Q39477975-7A96303D-5D15-4988-B481-20E20EE6E2B9Q39499604-F54C232B-9914-4EE0-A315-B1B94931AF01Q39685657-4E0A670B-E423-4109-B0B0-471A4BDA2180Q39691189-6E902A1A-367F-4EFB-AD12-A4B2AA0E3C17Q40183239-F5EDABC8-BD6D-4888-A3BE-08F2169AD7C1Q40476641-0D1B9A45-13EB-45B2-AC87-140552206422Q42129004-C0611C59-F714-40D8-8B53-B7C24B96BFCAQ42199666-7D31ECA2-4A3F-4EBF-B564-8A792666F906Q42489798-DB947343-E122-4481-AF5D-3FB03DAFCED6Q43107994-3BE30D27-577B-489E-A549-F1E433043353Q43642254-161D0236-1FA7-43BA-A041-E2FDAB1CC8CE
P2860
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@en
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@nl
type
label
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@en
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@nl
prefLabel
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@en
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@nl
P2093
P2860
P1433
P1476
Detailed mapping of prostate carcinoma foci: biopsy strategy implications.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D
P407
P577
2000-10-01T00:00:00Z